Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma

Clinical trial NCT03943667 · COMPLETED

Trial details

NCT number: NCT03943667
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma

Start date: 2019-05-23
Primary completion: 2022-04-26
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.